Mirum Pharmaceuticals (MIRM) Other Operating Expenses (2021 - 2026)

Mirum Pharmaceuticals' Other Operating Expenses history runs 6 years deep, the most recent figure standing at $755.1 million for Q1 2026.

• In Q1 2026, Other Operating Expenses rose 2595.08% year-over-year to $755.1 million; the TTM figure through Mar 2026 stood at $832.3 million (up 806.37% YoY), while the FY2025 annual figure was $100.2 million, up 22.78% from the prior year.
• Other Operating Expenses was $755.1 million for Q1 2026 at Mirum Pharmaceuticals, up from $28.3 million in the prior quarter.
• In the past five years, Other Operating Expenses ranged from a high of $755.1 million in Q1 2026 to a low of $2.4 million in Q1 2022.
• Historically, Other Operating Expenses has averaged $58.9 million across 5 years, with a median of $20.2 million in 2024.
• The sharpest annual moves came in 2024 and 2026: Other Operating Expenses fell 8.95% in 2024, then jumped 2595.08% in 2026.
• A 5-year view of Other Operating Expenses shows it stood at $4.5 million in 2022, then surged by 456.74% to $25.0 million in 2023, then fell by 8.95% to $22.8 million in 2024, then gained by 24.07% to $28.3 million in 2025, then jumped by 2571.62% to $755.1 million in 2026.
• The last three Other Operating Expenses figures came in at $755.1 million (Q1 2026), $28.3 million (Q4 2025), and $25.5 million (Q3 2025), per Business Quant data.